Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
Denali Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 18, 2019
Denali Therapeutics reported fiscal year 2018 executive compensation information on April 18, 2019.
In 2018, four executives at Denali Therapeutics received on average a compensation package of $4.5M, a 258% increase compared to previous year.
Average pay of disclosed executives at Denali Therapeutics
Ryan J. Watts, Chief Executive Officer, received $6M in total, which increased by 338% compared to 2017. 82% of Watts' compensation, or $4.9M, was in option awards. Watts also received $525K in bonus and $545K in salary.
Steve E. Krognes, Chief Financial Officer, received a compensation package of $4M, which increased by 243% compared to previous year. 74% of the compensation package, or $2.9M, was in option awards.
Carole Ho, Chief Medical Officer, earned $3.9M in 2018, a 188% increase compared to previous year.
Alexander O. Schuth, Chief Operating Officer, received $3.9M in 2018, which increases by 262% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 18, 2019.